Study on the mechanism of action of effective monomeric, berberine of Xianglian Pill in inhibiting human colon cancer cells based on fatty acid synthase target

10.1016/j.jtcme.2023.05.008

Shi-ying Li；Yun Li；Zhong-hua Wu；Zhang-jie Zhou；Cun-ya Li；Ting-ting Wu；Shu-juan Fu；Zhi-ying Wang；Zhi-xian Zhong；Yi Zhong

Xianglian Wan ； Xianglian pills ； Berberine ； Fatty acid synthase ； Acetyl CoA carboxylase ； Colorectal adenocarcinoma ； Lipid metabolism

Journal of Traditional and Complementary Medicine

13卷6期（2023 / 11 / 01）

538 - 549

英文

Background and aim: Xianglian Wan (XLW) as a classic prescription of traditional Chinese medicine protects digestive function; however, few studies have investigated its anti-colorectal cancer effects. This study verified that the effective monomer berberine of XLW plays an antitumo r role by regulating the acetyl-CoA carboxylase (ACC)/fatty acid synthase (FASN) lipid metabolism-related signaling pathway. Experimental procedure: The connection between XLW and FASN was identified through literature mining, bioinformatics and structural biology. In vivo experiments verified the rationality of the antitumor effect of berberine by regulating the ACC/FASN pathway, and in vitro experiments verified the regulatory relationship between berberine and FASN. Results and conclusion: The most frequent Chinese medicine component in XLW was Coptis chinensis. Berberine, the active ingredient of XLW, has a FASN binding site. FASN expression is higher in tumor tissues than in normal tissues. FASN is related to colorectal adenocarcinoma occurrence and patient survival time. Experiments showed that XLW, berberine and orlistat (FASN inhibitor) can cooperate with palmitic acid (PA) to inhibit tumors in mice. Berberine can downregulate FASN and ACC expression in tumor tissues and inhibit the increase in acetyl-CoA, the intermediate product of exogenous PA intake. The mechanism by which berberine inhibits colon cancer cell proliferation by lowering lipids is related to its downregulation of FASN protein expression. The ACC/FASN signaling pathway is a critical pathway through which berberine, the effective monomer of XLW, plays an antitumor role in colon cancer.

1. Anjum, D,Jijnasa, B,Prachurjya, D(2018).Hexane-Isopropanolic Extract of Tungrymbai, a North-East Indian fermented soybean food prevents hepatic steatosis via regulating AMPK-mediated SREBP/FAS/ACC/HMGCR and PPARa/CPT1A/UCP2 pathways.Sci Rep,8(1),10021.
2. Arends, J,Baracos, V,Bertz, H,Bozzetti, F(2017).ESPEN expert group recommendations for action against cancerrelated Malnutrition.Clin Nutr,36,1187-1196.
3. Bensaad, Karim,Elena(2014).Fatty acid uptake and lipid storage induced by HIF1a contribute to cell growth and survival after hypoxia-reoxygenation.Cell Rep,9(1),349-365.
4. Bolong, W,Yuewen, L(2018).Network pharmacological study on the action mechanism of Xianglian pills.Chin J Pharm,53(24),2079-2089.
5. Chan, KS,Cheung, SM,Senn, N(2022).Peri-tumoural spatial distribution of lipid composition and tubule formation in breast cancer.BMC Cancer,22(1),285.
6. Chen, YX,Gao, QY,Zou, TH(2020).Berberine versus placebo for the prevention of recurrence of colorectal adenoma: a multicentre, double-blinded, randomized controlled study.Lancet Gastroenterol Hepatol,5(3),267-275.
7. Farraye, FA,Odze, RD,Eaden, J(2010).AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease.Gastroenterology,138(2),738-745.
8. Hongsheng, L,Pingping, L,Dong, X(2016).Expert consensus on the use of proprietary Chinese medicine in palliative treatment of tumor (2013 version).Chin J Integ Trad Chin Western Med,36(3),269-279.
9. Jianxia, W,Yang, L,Junjie, H(2019).Study on the mechanism of Huanglian-Muxiang in the treatment of ulcerative colitis based on network pharmacology.J Dali Univ,4(10),32-39.
10. Jieyao, H,Danning, L,Lujia, Y(2020).Experimental study on acute and long-term toxicity of active components of Xianglian pills.J Southwest Univ,42(8),33-41.
11. Kong, W,Wei, J,Abidi, P(2004).Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins.Nat Med,10(12),1344-1351.
12. Kuang, H(2021).,Wuhan University.
13. Leporq, B,Lambert, SA,Ronot, M(2014).Quantification of the triglyceride fatty acid composition with 3.0 T MRI.NMR Biomed,27(10),1121-1221.
14. Lin, L,Ding, Y,Wang, Y(2017).Functional lipidomics: palmitic acid impairs hepatocellular carcinoma development by modulating membrane fluidity and glucose metabolism.Hepatology
15. Lin, L,Ding, Y,Wang, Y(2017).Functional lipidomics: palmitic acid impairs hepatocellular carcinoma development by modulating membrane fluidity and glucose metabolism.Hepatology,66(2),432-448.
16. Liu, CS,Xia, T,Luo, ZY(2021).Network pharmacology and pharmacokinetics integrated strategy to investigate the pharmacological mechanism of Xianglian pill on ulcerative colitis.Phytomedicine,82,153458.
17. Lu, J,Lin, Z,Huang, S(2020).Jiawei Xianglian decoction (JWXLD), a traditional Chinese medicine (TCM), alleviates CPT-11-induced diarrhea in nude mice.Evid Based Comp Alternat Med,2020,7901231.
18. Lu, M,Xiong, S,Mou, YL(2018).Progress in the study of chemical composition and pharmacological effects of Lian Pills.Chem Eng,32(12),68-71.
19. Mika, A,Kobiela, J,Czumaj, A(2017).Hyper-elongation in colorectal cancer tissue -cerotic acid is a potential novel serum metabolic marker of colorectal malignancies.Cell Physiol Biochem,41(2),722-730.
20. Min, L,Shan, X,Yanling, M(2019).Determination of main components in Xianglian pills by high performance liquid chromatography-tandem mass spectrometry.Chin Modern Trad Chin Med,21(12),1710-1714.
21. Mm, A,Ja, B,Pb, C(2021).ESPEN practical guideline: clinical Nutrition in cancer.Clin Nutr,40(5),2898-2913.
22. Ogino, S,Nosho, K,Meyerhardt, JA(2008).Cohort study of fatty acid synthase expression and patient survival in colon cancer.J Clin Oncol,26(35),5713-5720.
23. Pakiet, A,Stepnowski, P,Sledzinski, T(2019).Changes in lipids composition and metabolism in colorectal cancer: a review.Lipids Health Dis,18(29),29.
24. Peciuliene, I,Vilys, L,Jakubauskiene, E(2019).Exper Cell Res,380(1),29.
25. Qiang, Z(2016).Effects of mesalazine combined with Xianglian pills on cytokines and immune cells in patients with ulcerative colitis.Chin J Biochem Drugs,36(6),148-150.
26. Sadowski, MC,Pouwer, RH,Gunter, JH,Lubik, AA,Quinn, RJ,Nelson, CC(2015).The fatty acid synthase inhibitor triclosan: repurposing an anti-microbial agent for targeting prostate cancer.Oncotarget,5(19),9362-9381.
27. Shuting, T,Guibin, L,Jiaqian, G(2021).Based on network pharmacology and molecular docking, to explore the molecular mechanism of Xianglian pills in the treatment of ulcerative colitis.New Drug Trad Chin Med Clin Pharmacol,32(3),365-373.
28. Sung, H,Ferlay, J,Siegel, RL(2021).Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA A Cancer J Clin,71(3),209-249.
29. Tan, SH,Shui, G,Zhou, J(2012).Induction of autophagy by palmitic acid via protein kinase C;mediated signaling pathway independent of mTOR (mammalian target of rapamycin).J Biol Chem,287,14364-14376.
30. Wang, H,Xi, Q,Wu, G(2016).Fatty acid synthase regulates invasion and metastasis of colorectal cancer via Wnt signaling pathway.Cancer Med,5(7),1599-1606.
31. Wang, SL,Zeng, YE,Jia, W(2011).Effect of berberine in combination with thickened phenolics on cholesterol efflux from THP-1 foam cells.Lishizhen Med Materia Medica Res,22(4),910-911.
32. Xiaofeng, W,Guodong, L,Shumei, M(2010).Correlation between the distribution and evolution of TCM syndromes and clinicopathological stages in perioperative period of colorectal cancer.Beijing Trad. Chin Med,8,580-582.
33. Xinfeng, Z,Cuixia, Q,Xufeng, C(2016).Effects of Xianglian Pill on survival time and pro-inflammatory factors in ileum of nude mice with chemotherapy associated diarrhea.Liaoning J Trad Chin Med,43(12),2661-2663+2704.
34. Yan, D,Jingen, L(2016).Effect of Xianglian Pill on apoptosis and expression of Bcl-2 and BaxmRNA in rats with ulcerative colitis.Huaxi Med,31(6),1046-1051.
35. Ying, H,Qingyu, C,Yan, Z(2019).Effect of Xianglian Pill on oxidative stress-mediated autophagy in nude mice with acute ulcerative colitis.Emerg Trad Chin Med,28(5),851-853+862.
36. Ying, Z,Yuanyuan, Y,Yawei, D(2020).Systematic review and Meta analysis of efficacy and safety of berberine in the treatment of dyslipidemia in randomized controlled clinical trials.Chin J Trad Chin Med,45(3),664-673.
37. Youshan, C(2016).The relationship between uridine diphosphate glucuronosyl-transferase 1A1~*6 and uridine diphosphate glucuronosyltransferase~*28 gene polymorphism and the efficacy and adverse reactions of irinotecan.Clin Oncol and Rehab China,23(2),170-173.
38. Yun, Z(2014).,Nanhua University.
39. Zaytseva, YY,Elliott, VA,Rychahou, P(2014).Cancer cell-associated fatty acid synthase activates endothelial cells and promotes angiogenesis in colorectal cancer.Carcinogenesis,35(6),1341-1351.
40. Zaytseva, YY,Harris, JW,Mitovl, MI(2015).Increased expression of fatty acid synthase provides a survival advantage to colorectal cancer cells via upregulation of cellular respiration.Oncotarget,6(22),18891-18904.